FUNDAMENTALS OF CHEMOTHERAPY
IMMUNOTHERAPY ADMINISTRATION ACTUAL
EXAM PAPER 2026 QUESTIONS ANSWERS
GRADED A+
◉ Leukemia. Answer: cancer starts in blood-forming tissues like
bone marrow
-causes lots of abnormal blood cells to be produced and enter
bloodstream
◉ Lymphoma. Answer: -cancer that begins in immune system
(WBC=lymphocytes)
-hodgkin and non-hodgkins
-B lymphocytes (B cells) - make antibodies (bacteria and viruses,
most common lymphoma
-T lymphocytes (T cells) - boost/slow immune, destroy germs and
abnormal cells
◉ Hodgkin lymphoma. Answer: Reed-Sternberg cell (cancer cells in
classic)
-typically starts in B cells
,◉ Non-Hodgkin's Lymphoma. Answer: -large, diverse group of
cancers in immune system cells
-indolent (slow growing) or aggressive (fast)
◉ Myeloma. Answer: Cancer in plasma cells (WBC that produce
antibodies)
◉ Chemotherapy. Answer: All antineoplastic agents used to treat
cancer, given through oral and parenteral routes or other routes as
specified in the standard, not including hormonal therapies.
◉ Who can order chemotherapy?. Answer: Written and signed by
licensed independent practitioners (MD/DO, PA, Oncology NP)
◉ Can you use verbal orders for chemotherapy?. Answer: NO! Only
when holding/stopping admin.
◉ Who can mix Chemotherapy?. Answer: Pharmacist, Pharmacy
tech, MD/DO, qualified RN
◉ Who can administer chemotherapy?. Answer: Registered Nurses
with specialized education, prep and training. See specific state laws
and statutes
, ◉ How often is chemo competency reassessed>. Answer: Annual
continuing ed and competency assessment is recommended
◉ What is the dose verification process?. Answer: -confirm plan with
patient
-two practitioners verify: drug name, dose, volume, rate, route,
expiration date, appearance
-document verification in chart
◉ What PPE is required for IV Chemotherapy?. Answer: -Gloves: two
pairs, HD tested
-Gown: disposable, back closed, long sleeved
-Respirator: NIOSH approved
-Eye & Face: face shield/mask
◉ Neoadjuvant therapy (tumor burden). Answer: Chemo BEFORE
primary treatment (common in breast and colon)
◉ Adjuvant therapy. Answer: Chemo AFTER primary treatment
(common in solid tumor)
◉ Bone Marrow. Answer: soft, sponge-like tissue in center of most
bones, produce WBC, RBC, and platelets.
IMMUNOTHERAPY ADMINISTRATION ACTUAL
EXAM PAPER 2026 QUESTIONS ANSWERS
GRADED A+
◉ Leukemia. Answer: cancer starts in blood-forming tissues like
bone marrow
-causes lots of abnormal blood cells to be produced and enter
bloodstream
◉ Lymphoma. Answer: -cancer that begins in immune system
(WBC=lymphocytes)
-hodgkin and non-hodgkins
-B lymphocytes (B cells) - make antibodies (bacteria and viruses,
most common lymphoma
-T lymphocytes (T cells) - boost/slow immune, destroy germs and
abnormal cells
◉ Hodgkin lymphoma. Answer: Reed-Sternberg cell (cancer cells in
classic)
-typically starts in B cells
,◉ Non-Hodgkin's Lymphoma. Answer: -large, diverse group of
cancers in immune system cells
-indolent (slow growing) or aggressive (fast)
◉ Myeloma. Answer: Cancer in plasma cells (WBC that produce
antibodies)
◉ Chemotherapy. Answer: All antineoplastic agents used to treat
cancer, given through oral and parenteral routes or other routes as
specified in the standard, not including hormonal therapies.
◉ Who can order chemotherapy?. Answer: Written and signed by
licensed independent practitioners (MD/DO, PA, Oncology NP)
◉ Can you use verbal orders for chemotherapy?. Answer: NO! Only
when holding/stopping admin.
◉ Who can mix Chemotherapy?. Answer: Pharmacist, Pharmacy
tech, MD/DO, qualified RN
◉ Who can administer chemotherapy?. Answer: Registered Nurses
with specialized education, prep and training. See specific state laws
and statutes
, ◉ How often is chemo competency reassessed>. Answer: Annual
continuing ed and competency assessment is recommended
◉ What is the dose verification process?. Answer: -confirm plan with
patient
-two practitioners verify: drug name, dose, volume, rate, route,
expiration date, appearance
-document verification in chart
◉ What PPE is required for IV Chemotherapy?. Answer: -Gloves: two
pairs, HD tested
-Gown: disposable, back closed, long sleeved
-Respirator: NIOSH approved
-Eye & Face: face shield/mask
◉ Neoadjuvant therapy (tumor burden). Answer: Chemo BEFORE
primary treatment (common in breast and colon)
◉ Adjuvant therapy. Answer: Chemo AFTER primary treatment
(common in solid tumor)
◉ Bone Marrow. Answer: soft, sponge-like tissue in center of most
bones, produce WBC, RBC, and platelets.
